New $25M VC Fund Looking At Psychedelics And Neurotechnology To Tackle Global Mental Health Crisis
A new $25 million venture fund is going all-in on psychedelic medicine.
PsyMed is an entrepreneur-led VC fund with a focus on psychedelic medicine, precision psychiatry and neurotechnology. The fund’s goal is to support innovative solutions to solve today’s ongoing mental health crisis.
